IVIG IS OUR MIDDLE NAME

CSL Behring AG

Application Filed: 2019-04-03
Trademark Application Details
Trademark Logo IVIG IS OUR MIDDLE NAME

Mark For: IVIG IS OUR MIDDLE NAME™ trademark registration is intended to cover the categories of providing a website featuring information in the field of immunoglobulin, immunodeficiency and neurological disorders, and corresponding treatments; Healthcare and healthcare information services, namely, providing information concerning immunoglobulin, immunodeficiency and neurological disorders, their treatment and their impact on patients, patient families, caregivers and/or healthcare professionals; Healthcare and healthcare information services, namely, providing information concerning patient lifestyle and wellness for patients, caregivers, parents, teachers, coaches and friends impacted by immunoglobulin, immunodeficiency and neurological disorders; Providing a website featuring information in the field of the diagnosis and treatment of immunoglobulin, immunodeficiency and neurological disorders; Providing links to the web sites of others featuring information about the diagnosis and treatment of immunoglobulin, immunodeficiency and neurological disorders. [all]

Status

2020-06-25 UTC
LIVE APPLICATION Published for Opposition
A pending trademark application has been examined by the Office and has been published in a way that provides an opportunity for the public to oppose its registration.


Research OneLook Acronym Finder
Serial Number88368976
Mark Literal ElementsIVIG IS OUR MIDDLE NAME
Mark Drawing Type4 - STANDARD CHARACTER MARK
Mark TypeTRADEMARK. SERVICE MARK
RegisterPRINCIPAL
Current LocationINTENT TO USE SECTION 2020-03-10
Basis1(b)
Class StatusACTIVE
Primary US Classes
  • 100: Miscellaneous
  • 101: Advertising and Business
Primary International Class
  • 044 - Primary Class
  • (Medical, beauty & agricultural) Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
Filed UseNo
Current UseNo
Intent To UseYes
Filed ITUYes
44D FiledNo
44E CurrentNo
66A CurrentNo
Current BasisNo
No BasisNo
Attorney NameScott D. Woldow
Attorney Docket Number034845.184
Law Office AssignedN70
Employee NameTHOMAS-RIGGS, LESLIE A

Timeline

2019-04-03Application Filed
2019-12-12Location: PUBLICATION AND ISSUE SECTION
2019-12-12Status: Live/Pending
2019-12-25Transaction Date
2020-01-14Published
2020-01-14Published for Opposition
2020-03-10Location: INTENT TO USE SECTION
2020-03-10Status: Notice of Allowance (NOA) sent (issued) to the applicant. Applicant must file a Statement of Use or Extension Request within six

Trademark Parties (Applicants & Owners)

Party: CSL Behring AG
AddressWankdorfstrasse 10 Bern SWITZERLAND 3014
Legal Entity TypeAktiengesellschaft (ag)
Legal Entity StateSWITZERLAND

Documents

DrawingIMAGE/JPEG2019-04-03
TEAS RF New ApplicationAPPLICATION/XML,IMAGE/JPEG2019-04-03
XSearch Search SummaryXML2019-06-19
XSearch Search SummaryXML2019-06-19
Examiners Amendment PriorityMULTI2019-06-20
Notation to FileXML2019-06-20
Notation to FileXML2019-06-20
Response to Office ActionAPPLICATION/XML,IMAGE/TIFF2019-12-09
Amendment and Mail Process CompleteMULTI2019-12-10
TRAM Snapshot of App at Pub for OppostnMULTI2019-12-11
Notice of PublicationXML2019-12-25
Notification Of Notice of PublicationXML2019-12-25
OG Publication ConfirmationXML2020-01-14
Notice of AllowanceXML2020-03-10

Attorney of Record

Scott D. Woldow
SMITH, GAMBRELL & RUSSELL, LLP
SUITE 400
1055 THOMAS JEFFERSON ST. NW
WASHINGTON DC 20007

Good, Services, and Codes


IC 016. US 002 005 022 023 029 037 038 050. G & S: Printed materials, namely, newsletters, articles and case studies featuring immunoglobulin, immunodeficiency and neurological disorders; Printed publications, namely, brochures, booklets, newsletters, articles, case studies, and teaching materials in the field of immunoglobulin, immunodeficiency and neurological disorders; printed educational materials in the field of immunoglobulin, immunodeficiency and neurological disorders
IC 035. US 100 101 102. G & S: Healthcare education services, namely, promoting awareness of immunoglobulin, immunodeficiency and neurological disorders, its treatment and its impact on patients, patient families, caregivers and/or healthcare professionals to patients, caregivers and/or healthcare professionals
IC 041. US 100 101 107. G & S: Healthcare education services, namely, conducting educational programs for patients, caregivers and/or healthcare professionals concerning immunoglobulin, immunodeficiency and neurological disorders, its treatment and its impact on patients, patient families, caregivers and/or healthcare professionals; planning and conducting educational conventions and educational meetings related to immunoglobulin, immunodeficiency and neurological disorders, their treatment and their impact on patients, patient families, caregivers and/or healthcare professionals
IC 044. US 100 101. G & S: Providing a website featuring information in the field of immunoglobulin, immunodeficiency and neurological disorders, and corresponding treatments; Healthcare and healthcare information services, namely, providing information concerning immunoglobulin, immunodeficiency and neurological disorders, their treatment and their impact on patients, patient families, caregivers and/or healthcare professionals; Healthcare and healthcare information services, namely, providing information concerning patient lifestyle and wellness for patients, caregivers, parents, teachers, coaches and friends impacted by immunoglobulin, immunodeficiency and neurological disorders; Providing a website featuring information in the field of the diagnosis and treatment of immunoglobulin, immunodeficiency and neurological disorders; Providing links to the web sites of others featuring information about the diagnosis and treatment of immunoglobulin, immunodeficiency and neurological disorders

International Codes:16
U.S. Codes:002,005,022,023,029,037,038,050
International Codes:35
U.S. Codes:100,101,102
International Codes:41
U.S. Codes:100,101,107
International Codes:44
U.S. Codes:100,101
Type CodeType
D10000"IVIG"

Trademark Filing History

DescriptionDateProceeding Number
NOA E-MAILED - SOU REQUIRED FROM APPLICANT2020-03-10
PUBLISHED FOR OPPOSITION2020-01-14
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED2020-01-14
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED2019-12-25
APPROVED FOR PUB - PRINCIPAL REGISTER2019-12-10
TEAS/EMAIL CORRESPONDENCE ENTERED2019-12-0988889
TEAS RESPONSE TO OFFICE ACTION RECEIVED2019-12-09
CORRESPONDENCE RECEIVED IN LAW OFFICE2019-12-0988889
NOTIFICATION OF EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED2019-06-206326
EXAMINERS AMENDMENT AND/OR PRIORITY ACTION - COMPLETED2019-06-2093678
EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED2019-06-206326
COMBINED EXAMINER'S AMENDMENT/PRIORITY ACTION AUTOMATIC ENTRY2019-06-2093678
ASSIGNED TO EXAMINER2019-06-1293678
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM2019-04-20
NEW APPLICATION ENTERED IN TRAM2019-04-06

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed